Status:
COMPLETED
Evaluation of Relationship Between Preoperative Fibrinogen/Albumin Ratio and Morbidity After Hip Fracture Operations
Lead Sponsor:
Istanbul University
Conditions:
Hip Fractures
Albumin
Eligibility:
All Genders
85+ years
Brief Summary
Due to the aging of populations, hip fracture operations are increasing from year to year. This operations have many complications also high morbidity and the mortality. Population of this study is ol...
Detailed Description
Due to the aging of populations, hip fracture operations are increasing from year to year. This operations have many complications also high morbidity and the mortality. Elderly people are divided int...
Eligibility Criteria
Inclusion
- ≥85 years old patients
- Primary operation
- Undergoing hip fracture surgery
- Receiving consent from patients or guardians that they accept regional anesthesia
- Not having active infection
- American Society of Anesthesiologists (ASA) 1-4
- BMI\< 40 kg/m²
Exclusion
- Refusal regional anesthesia
- Infection on regional anesthesia application area
- Infection in the central nervous system
- Coagulopathy
- Known allergy against local anesthetics
- Severe hepatic insufficiency
- Haematologic disease
- Rheumatological disease
- Autoimmune disease
Key Trial Info
Start Date :
March 30 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2023
Estimated Enrollment :
108 Patients enrolled
Trial Details
Trial ID
NCT05272072
Start Date
March 30 2022
End Date
March 1 2023
Last Update
March 2 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istanbul University
Istanbul, Fatih, Turkey (Türkiye), 34093